2.2 Imminent generics entry Semaglutide, the biggest blockbuster product in the GLP-1 market today, is expected to lose patent protection in China in 2026, earlier than in most developed markets
Use no more than once or twice per week, as regular use can lead to dependency and actually worsen constipation over time
A platform that says "our medication" while sourcing from a third-party compounder - and doesn't make that clear - was specifically cited as a violation type
Our experienced providers lead the weight loss program with expertise and compassion, offering ongoing, unmatched support and guidance toward your weight loss goals
With obesity affecting 70% of American adults, many in Glendale can benefit from this effective treatment, which provides lasting results for those struggling with weight management
Gastrointestinal adverse events leading to treatment discontinuation occur in approximately 4-5% of patients on Wegovy, with diarrhea being one contributing factor